1. Home
  2. MAMA vs NKTX Comparison

MAMA vs NKTX Comparison

Compare MAMA & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mama's Creations Inc.

MAMA

Mama's Creations Inc.

HOLD

Current Price

$12.95

Market Cap

474.8M

ML Signal

HOLD

Logo Nkarta Inc.

NKTX

Nkarta Inc.

HOLD

Current Price

$1.87

Market Cap

129.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAMA
NKTX
Founded
2010
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
474.8M
129.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
MAMA
NKTX
Price
$12.95
$1.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$17.00
$13.25
AVG Volume (30 Days)
626.0K
641.1K
Earning Date
12-08-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
41.91
N/A
EPS
0.12
N/A
Revenue
$151,312,000.00
N/A
Revenue This Year
$39.64
N/A
Revenue Next Year
$28.85
N/A
P/E Ratio
$108.14
N/A
Revenue Growth
29.92
N/A
52 Week Low
$5.50
$1.31
52 Week High
$14.97
$2.74

Technical Indicators

Market Signals
Indicator
MAMA
NKTX
Relative Strength Index (RSI) 51.66 52.06
Support Level $13.24 $1.79
Resistance Level $13.90 $1.90
Average True Range (ATR) 0.60 0.06
MACD -0.14 0.01
Stochastic Oscillator 6.68 82.50

Price Performance

Historical Comparison
MAMA
NKTX

About MAMA Mama's Creations Inc.

Mama's Creations Inc is a marketer and manufacturer of fresh deli-prepared foods, found in grocery, mass, club, and convenience stores nationally. The company's broad product portfolio, born from a rich history in Italian foods, now consists of a variety of high-quality, fresh, clean, and easy-to-prepare foods to address the needs of both consumers and retailers. The brand of the company includes Mama's Creations, Mama's Mancini's, The Olive Branch, Creative Salads, and others.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: